biomarker study of the effect and adverse event for neoadjuvantchemotherapy with breast cancer patinets

biomarker study of the effect and adverse event for neoadjuvantchemotherapy with breast cancer patinets - biomarker study for breast cancer neoadjuvant chemotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002324

Enrollment

180

Registered

2009-08-11

Start date

2007-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) patients approved informed consent 2) patients who will recieve neoajuvant chemotherapy including Anthracycline and Taxane 3) patinents with measurable lesion with breast ultrasonography 4) patients without concomitant malignancy other than carcinoma in situ

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
pahological complete response	—

Countries

Japan

Contacts

Public ContactFumiaki Koizumi

national cancer center Shi-en Shisetu

NCC_IRBoffice@ml.res.ncc.go.jp

Outcome results